No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.

V T MückeM M MückeKai-Hendrik PeifferN WeilerT M WelzelC SarrazinS ZeuzemA BergerJohannes Vermehren

Published in: Alimentary pharmacology & therapeutics (2017)

HBV reactivation was not observed in HBsAg-negative/HBcAb-positive patients but common in HBsAg-positive/HBcAb-positive patients treated with different combinations of DAAs for HCV.

Keyphrases

hepatitis b virus
liver failure
newly diagnosed
end stage renal disease
hepatitis c virus
peritoneal dialysis
human immunodeficiency virus